FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,015,000 | -43.7% | 77,774 | -15.1% | 0.00% | -33.3% |
| Q4 2021 | $5,359,000 | +4.5% | 91,593 | +5.9% | 0.00% | 0.0% |
| Q3 2021 | $5,126,000 | -34.9% | 86,488 | -4.6% | 0.00% | -25.0% |
| Q2 2021 | $7,871,000 | +12.6% | 90,687 | +7.0% | 0.00% | 0.0% |
| Q1 2021 | $6,990,000 | -2.4% | 84,777 | +7.7% | 0.00% | 0.0% |
| Q4 2020 | $7,160,000 | +192.2% | 78,740 | +28.5% | 0.00% | +100.0% |
| Q3 2020 | $2,450,000 | +24.6% | 61,290 | +6.9% | 0.00% | 0.0% |
| Q2 2020 | $1,967,000 | +45.6% | 57,328 | -5.7% | 0.00% | +100.0% |
| Q1 2020 | $1,351,000 | +210.6% | 60,812 | +173.4% | 0.00% | – |
| Q4 2019 | $435,000 | +39.4% | 22,240 | +10.6% | 0.00% | – |
| Q3 2019 | $312,000 | -10.9% | 20,110 | +16.5% | 0.00% | – |
| Q2 2019 | $350,000 | +37.3% | 17,263 | +19.1% | 0.00% | – |
| Q1 2019 | $255,000 | +33.5% | 14,500 | -2.6% | 0.00% | – |
| Q4 2018 | $191,000 | -4.0% | 14,886 | +22.1% | 0.00% | – |
| Q3 2018 | $199,000 | +29.2% | 12,189 | -10.2% | 0.00% | – |
| Q2 2018 | $154,000 | -83.4% | 13,573 | -85.7% | 0.00% | -100.0% |
| Q1 2018 | $929,000 | +1155.4% | 95,154 | +690.7% | 0.00% | – |
| Q4 2017 | $74,000 | – | 12,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |